Home Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
Article
Licensed
Unlicensed Requires Authentication

Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands

  • Ingeborg H. Linskens , Marieke Levitus , Anneke Frans , Peter C.J.I. Schielen , John M.G. van Vugt , Marinus A. Blankenstein and Hilde M. Dijstelbloem
Published/Copyright: February 1, 2009

Abstract

Background: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free β-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system.

Methods: A total of 40 serum samples were aliquoted and stored at –20°C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years.

Results: The relationships between free β-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free β-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free β-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free β-hCG, the relationships were linear with slopes of 1.08 and 1.07.

Conclusions: We demonstrate an excellent agreement for the analysis of PAPP-A and free β-hCG between Delfia Xpress systems and one AutoDelfia system.

Clin Chem Lab Med 2009;47:222–6.


Corresponding author: Prof. M.A. Blankenstein, Department of Clinical Chemistry, VU University Medical Center, PK1 BR 020, 1007 MB Amsterdam, The Netherlands Phone: +31-20-4443872, Fax: +31-20-4443895,

Received: 2008-7-1
Accepted: 2008-11-6
Published Online: 2009-02-01
Published in Print: 2009-02-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
  3. Reviews
  4. Vitamin D: current status and perspectives
  5. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
  6. New European guidelines for cardiovascular disease prevention in clinical practice
  7. Review
  8. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
  9. Genetics and Molecular Diagnostics
  10. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
  11. Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
  12. General Clinical Chemistry and Laboratory Medicine
  13. Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
  14. Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
  15. Methodology for monitoring cytomegalovirus infection after renal transplantation
  16. High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
  17. Reference Values and Biological Variations
  18. Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
  19. Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
  20. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
  21. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
  22. Validation and Outcome Studies
  23. Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
  24. Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
  25. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
  26. Letters to the Editor
  27. Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
  28. Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
  29. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.042/html?lang=en
Scroll to top button